Supernus Pharmaceuticals (SUPN) Consolidated Net Income (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted Consolidated Net Income of -$58.37 million for Q2 2026, compared with $22.5 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Consolidated Net Income (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Supernus Pharmaceuticals was -$85.12 million; for FY2025, it came in at -$38.55 million.
- In prior years, Supernus Pharmaceuticals' Consolidated Net Income was $73.87 million in FY2024, $1.32 million in FY2023 (-97.8%), $60.71 million in FY2022 (+13.6%) and $53.42 million in FY2021 (-57.9%).
- The Q2 2026 figure stands as the lowest quarterly Consolidated Net Income in data going back to Q1 2011.
- The strongest year-over-year quarter for Consolidated Net Income in the past five years was Q4 2022, with growth of 943.4%; the weakest was Q1 2024, with a decline of 99.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn | -58.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.37 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -45.12 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | -11.83 Mn |
| Dec 31, 2024 | 15.38 Mn |
| Sep 30, 2024 | 38.50 Mn |
| Jun 30, 2024 | 19.90 Mn |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | -16.01 Mn |
| Jun 30, 2023 | -827,000.00 |
| Mar 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 25.48 Mn |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 25.62 Mn |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | 21.56 Mn |
| Jun 30, 2021 | 23.73 Mn |
API Access
Supernus Pharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();